Comparison of the Administration of Levosimendan and Placebo in the Preparation of Critical Patients for Heart Surgery

Summary

This study aims to examine the efficacy of levosimendan in terms of reducing postoperative mortality and severe morbidity in patients undergoing non-emergent surgery for coronary revascularisation with or without ischaemic mitral regurgitation and who may or may not require repair or replacement of the mitral valve and have a LVEF \< 35%.

Timeline

Start

2011-02

Primary completion

2014-11

Completion

2014-11

Drugs

Indications